Renal failure in chronic liver disease and the hepatorenal syndrome

British Journal of Hospital Medicine

Volumn 72, Issue 9, 2011, Pages 497-503

  Alexander, Graeme J M ^a   Srivastava, Brijesh ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052991567     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2011.72.9.497     Document Type: Article

References (39)

1. Abraldes JG, Iwakiri Y, Loureiro-Silva M, Haq O, Sessa WC, Groszmann RJ (2006) Mild increases in portal pressure up-regulate VEGF and eNOS in the intestinal microcirculation leading to hyperdynamic state. Am J Physiol Gastrointest Liver Physiol 290(5): G980-7
2. Alessandria C, Ozdogan O, Guevara M et al (2005) MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation. Hepatology 41: 1282-9 (Pubitemid 40770280)
3. Arroyo V, Fernandez J, Gines P (2008) Pathogenesis and treatment of hepatorenal syndrome. Semin Liver Dis 28: 81-95 (Pubitemid 351326535)
4. Boyer TD, Sanyal AJ, Garcia-Tsao G, Blei A, Carl D, Bexon AS, Teuber P; Terlipressin Study Group (2011) Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics. J Hepatol 55(2): 315-21
5. Cardenas A, Gines P, Uriz J et al (2001) Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 34: 671-6 (Pubitemid 32927990)
6. du Cheyron D, Bouchet B, Parienti JJ, Ramakers M, Charbonneau P (2005) The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med 31(12): 1693-9 (Pubitemid 41677246)
7. European Association for the Study of the Liver (2010) EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 53(3): 397-417
8. Fasolato S, Angeli P, Dallagnese L et al (2007) Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features. Hepatology 45: 223-9 (Pubitemid 46144382)
9. Fernandez J, Navasa M, Garcia-Pagan JC et al (2004) Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. J Hepatol 41: 384-90 (Pubitemid 39158747)
10. Fernandez J, Navasa M, Planas R et al (2007) Primary prophylaxis of spontaneous bacterial peritonitis delays hepato-renal syndrome and improves survival in cirrhosis. Gastroenterology 133: 818-24 (Pubitemid 47374144)
11. Follo A, Llovet JM, Navasa M et al (1994) Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis. Hepatology 20: 1495-501 (Pubitemid 24359062)
12. Garcia-Tsao G, Parikh CR, Viola A (2008) Acute kidney injury in cirrhosis. Hepatology 46: 2064-77
13. Genecin P, Polio J, Groszmann RJ (1990) Na restriction blunts expansion of plasma volume and ameliorates hyperdynamic circulation in portal hypertension. Am J Physiol Gastrointest Liver Physiol 259: G498-G503
14. Gildea TR, Cook WC, Nelson DR et al (2004) Predictors of longterm mortality in patients with cirrhosis of the liver admitted to a medical ICU. Chest 126(5): 1598-603 (Pubitemid 39525036)
15. Ginès A, Escorsell A, Ginès P et al (1993) Incidence, predictive factors, and prognosis of hepatorenal syndrome in cirrhosis. Gastroenterology 105: 229-36 (Pubitemid 23234041)
16. Ginès P, Cárdenas A, Schrier RW (2007) Liver disease and the kidney. In: Schrier RW, ed. Diseases of the Kidney and Urinary Tract. Lippincott Williams & Wilkins, Philadelphia: 2179-205
17. Gluud LL, Christensen K, Christensen E, Krag A (2010) Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 51(2): 576-84
18. Guyton AC (1980) Arterial Pressure and Hypertension. WB Saunders, Philadelphia
19. Hampel H, Bynum GD, Zamora E, El-Serag HB (2001) Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol 96: 2206-10 (Pubitemid 32660919)
20. Helvig FC, Schutz CB (1932) A liver and kidney syndrome: Clinical, pathological, and experimental studies. Surg Gynecol Obstet 55: 570-82
21. Iwakiri Y, Groszmann RJ (2006) The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule. Hepatology 43: S121-S131
22. Mandell MS, Lindenfield J, Tsou M-Y, Zimmerman M (2008) Cardiac evaluation of liver transplant candidates. World J Gastroenterol 12: 3445-51
23. Martín-Llahí M, Guevara M, Torre A et al (2011) Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 140(2): 488-96
24. Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 11: R31
25. Moore K (1999) Renal failure in acute liver failure. Eur J Gastroenterol Hepatol 11: 967-75 (Pubitemid 29520551)
26. Moreau R, Lebrec D (2003) Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD. Hepatology 37: 233-43 (Pubitemid 36152520)
27. Moreau R, Lebrec D (2006) The use of vasoconstrictors in patients with cirrhosis: Type 1 HRS and beyond. Hepatology 43: 385-94
28. Narahara Y, Kanazawa H, Taki Y et al (2009) Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis. J Gastroenterol Hepatol 24(11): 1791-7
29. Ros J, Clària J, To-Figueras J et al (2002) Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 122: 85-93 (Pubitemid 34049198)
30. Salerno F, Gerbes A, Gines P, Wong F, Arroyo V (2007) Diagnosis, prevention and treatment of the hepato-renal syndrome in cirrhosis. Gut 56: 1310-18 (Pubitemid 47300435)
31. Schrier RW (1988) Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy. N Engl J Med 319(16): 1065-72
32. Sheer TA, Runyon BA (2005) Spontaneous bacterial peritonitis. Dig Dis 23: 39-46 (Pubitemid 40827661)
33. Slack A, Yeoman A, Wendon J (2010) Renal dysfunction in chronic liver disease. Crit Care 14(2): 214
34. Sort P, Navasa M, Arroyo V et al (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341: 403-9 (Pubitemid 29362513)
35. Takabatake T, Ohta H, Ishida Y, Hara H, Ushiogi Y, Hattori N (1988) Low serum creatinine levels in severe hepatic disease. Arch Intern Med 148: 1313-15
36. Terra C, Guevara M, Torre A et al (2005) Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: Value of MELD score. Gastroenterology 129: 1944-53 (Pubitemid 41772972)
37. Tomlanovich S, Golbetz H, Perlroth M, Stinson E, Myers BD (1986) Limitations of creatinine in quantifying the severity of cyclosporineinduced chronic nephropathy. Am J Kidney Dis 8: 332-7 (Pubitemid 17235079)
38. Verma S, Ajudia K, Mendler M et al (2006) Prevalence of septic events, type 1 hepatorenal syndrome, and mortality in severe alcoholic hepatitis and utility of discriminant function and MELD score in predicting these adverse events. Dig Dis Sci 51: 1637-43 (Pubitemid 44379309)
39. Wu CC, Yeung LK, Tsai WS et al (2006) Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis. Clin Nephrol 65: 28-33